Investor Relations

Overview

Medidata is reinventing global drug ​and medical device ​development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including nearly 850 global pharmaceutical companies, biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.

The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 17 of the world's top 25 global pharmaceutical companies and is used by 16 of the top 20 medical device developers—from study design and planning through execution, management and reporting.

Stock Quote

  • NASDAQ: MDSO
  • 63.34 Price:
  • 0.00 Change:
  • N/A Day High:
  • N/A Day Low:
  • N/A Volume:

Investor Contact

Anthony D'Amico
Senior Director, Investor Relations
+1 732 767 4331
adamico@mdsol.com